These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7638126)

  • 1. [Skin, a privileged target for gene therapy].
    Descamps V
    Presse Med; 1995 May; 24(19):882-4. PubMed ID: 7638126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genodermatoses: candidate diseases for gene therapy.
    Uitto J; Pulkkinen L
    Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated cutaneous gene delivery: the skin as a bioreactor.
    Cao T; Wang XJ; Roop DR
    Hum Gene Ther; 2000 Nov; 11(16):2297-300. PubMed ID: 11084689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery to the epidermis.
    Trainer AH; Alexander MY
    Hum Mol Genet; 1997; 6(10):1761-7. PubMed ID: 9300669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
    Braun-Falco M; Eisenried A; Büning H; Ring J
    Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes.
    Lu Z; Ghazizadeh S
    Exp Dermatol; 2005 Oct; 14(10):727-35. PubMed ID: 16176280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous gene transfer and therapy: the present and the future.
    Spirito F; Meneguzzi G; Danos O; Mezzina M
    J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
    Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
    Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblasts and dermal gene therapy: a minireview.
    Krueger GG
    Hum Gene Ther; 2000 Nov; 11(16):2289-96. PubMed ID: 11084688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic correction of inherited epidermal disorders.
    Khavari PA
    Hum Gene Ther; 2000 Nov; 11(16):2277-82. PubMed ID: 11084686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous gene therapy--an update.
    Christensen R; Jensen UB; Jensen TG
    Histochem Cell Biol; 2001 Jan; 115(1):73-82. PubMed ID: 11219611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Skin and gene therapy. Hopes and realities].
    Descamps V
    Ann Dermatol Venereol; 1995; 122(4):226-34. PubMed ID: 8526417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to achieve long-term expression in skin gene therapy.
    Therrien JP; Pfützner W; Vogel JC
    Toxicol Pathol; 2008 Jan; 36(1):104-11. PubMed ID: 18337228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
    Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
    Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
    Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocyte gene therapy.
    Vogel JC
    Arch Dermatol; 1993 Nov; 129(11):1478-83. PubMed ID: 8239704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
    Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production and applications of genetically modified skin cells.
    Bevan S; Martin R; Mckay IA
    Biotechnol Genet Eng Rev; 1999; 16():231-56. PubMed ID: 10819081
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in gene therapy for malignant melanoma.
    Sotomayor MG; Yu H; Antonia S; Sotomayor EM; Pardoll DM
    Cancer Control; 2002; 9(1):39-48. PubMed ID: 11907465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy and the skin].
    Hengge UR; Bardenheuer W; Doroudi R; Mirmohammadsadegh A
    Ann Dermatol Venereol; 2005 Feb; 132(2):154-63. PubMed ID: 15798569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.